Predicting Treatment Response for Oppositional Defiant and Conduct Disorder Using Pre-Treatment Adrenal and Gonadal Hormones

被引:11
作者
Shenk, Chad E. [1 ]
Dorn, Lorah D. [1 ]
Kolko, David J. [2 ]
Susman, Elizabeth J. [3 ]
Noll, Jennie G. [1 ]
Bukstein, Oscar G. [4 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA USA
[3] Penn State Univ, University Pk, PA 16802 USA
[4] Univ Texas Hlth Sci Ctr, Houston, TX USA
关键词
Oppositional defiant disorder; Conduct disorder; Testosterone; Cortisol; Treatment response; DISRUPTIVE BEHAVIOR DISORDERS; LOW SALIVARY CORTISOL; ANTISOCIAL-BEHAVIOR; ADOLESCENT GIRLS; CHILDREN; TESTOSTERONE; AGGRESSION; INTERVENTION; THERAPY; BOYS;
D O I
10.1007/s10826-011-9557-x
中图分类号
D669 [社会生活与社会问题]; C913 [社会生活与社会问题];
学科分类号
1204 ;
摘要
Variations in adrenal and gonadal hormone profiles have been linked to increased rates of oppositional defiant disorder (ODD) and conduct disorder (CD). These relationships suggest that certain hormone profiles may be related to how well children respond to psychological treatments for ODD and CD. The current study assessed whether pre-treatment profiles of adrenal and gonadal hormones predicted response to psychological treatment of ODD and CD. One hundred five children, 6-11 years old, participating in a randomized, clinical trial provided samples for cortisol, testosterone, dehydroepiandrosterone, and androstenedione. Diagnostic interviews of ODD and CD were administered up to 3 years post-treatment to track treatment response. Group-based trajectory modeling identified two trajectories of treatment response: (1) a High-response trajectory where children demonstrated lower rates of an ODD or CD diagnosis throughout follow-up, and (2) a Low-response trajectory where children demonstrated higher rates of an ODD or CD diagnosis throughout follow-up. Hierarchical logistic regression predicting treatment response demonstrated that children with higher pre-treatment concentrations of testosterone were four times more likely to be in the Low-response trajectory. No other significant relationship existed between pre-treatment hormone profiles and treatment response. These results suggest that higher concentrations of testosterone are related to how well children diagnosed with ODD or CD respond to psychological treatment over the course of 3 years.
引用
收藏
页码:973 / 981
页数:9
相关论文
共 50 条
  • [41] Predicting Response to Systemic Chemotherapy for Advanced Gastric Cancer Using Pre-Treatment Dual-Energy CT Radiomics: A Pilot Study
    Liu, Yi-yang
    Zhang, Huan
    Wang, Lan
    Lin, Shu-shen
    Lu, Hao
    Liang, He-jun
    Liang, Pan
    Li, Jun
    Lv, Pei-jie
    Gao, Jian-bo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] The prospective usefulness of callous–unemotional traits and conduct disorder in predicting treatment engagement among detained girls
    Olivier F. Colins
    Lore Van Damme
    Kostas A. Fanti
    Henrik Andershed
    European Child & Adolescent Psychiatry, 2017, 26 : 75 - 85
  • [43] Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study
    Dell'Agnello, Grazia
    Maschietto, Dino
    Bravaccio, Carmela
    Calamoneri, Filippo
    Masi, Gabriele
    Curatolo, Paolo
    Besana, Dante
    Mancini, Francesca
    Rossi, Andrea
    Poole, Lynne
    Escobar, Rodrigo
    Zuddas, Alessandro
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 (11) : 822 - 834
  • [44] Predicting treatment response using pharmacy register in migraine
    Hansen, Thomas Folkmann
    Chalmer, Mona Ameri
    Haspang, Thilde Marie
    Kogelman, Lisette
    Olesen, Jes
    JOURNAL OF HEADACHE AND PAIN, 2019, 20
  • [45] Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary report
    Hough, Christina M.
    Bersani, F. Saverio
    Mellon, Synthia H.
    Morford, Alexandra E.
    Lindqvist, Daniel
    Reus, Victor I.
    Epel, Elissa S.
    Wolkowitz, Owen M.
    PSYCHOLOGICAL MEDICINE, 2021, 51 (12) : 2117 - 2125
  • [46] Pre-treatment Predictors of Response for Assessing Outcomes to Standard Treatment in Infection with HCV Genotype 3
    Qureshi, Saleem
    Batool, Uzma
    Iqbal, Mussarat
    Burki, Umar Farooq
    Khan, Naqeeb Ullah
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (02): : 64 - 68
  • [47] Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 report
    Harris, Jacqueline K.
    Hassel, Stefanie
    Davis, Andrew D.
    Zamyadi, Mojdeh
    Arnott, Stephen R.
    Milev, Roumen
    Lam, Raymond W.
    Frey, Benicio N.
    Hall, Geoffrey B.
    Muller, Daniel J.
    Rotzinger, Susan
    Kennedy, Sidney H.
    Strother, Stephen C.
    MacQueen, Glenda M.
    Greiner, Russell
    NEUROIMAGE-CLINICAL, 2022, 35
  • [48] Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study
    Mao, Yitao
    Pei, Qian
    Fu, Yan
    Liu, Haipeng
    Chen, Changyong
    Li, Haiping
    Gong, Guanghui
    Yin, Hongling
    Pang, Peipei
    Lin, Huashan
    Xu, Biaoxiang
    Zai, Hongyan
    Yi, Xiaoping
    Chen, Bihong T.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy
    Lan, Ailin
    Jin, Yudi
    Wang, Yu
    Wang, Yihua
    Ding, Nan
    Dai, Yuran
    Jiang, Linshan
    Tang, Zhenrong
    Peng, Yang
    Liu, Shengchun
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (05) : 899 - 910
  • [50] Pre-treatment circulating reproductive hormones levels predict pathological and survival outcomes in breast cancer submitted to neoadjuvant chemotherapy
    Ailin Lan
    Yudi Jin
    Yu Wang
    Yihua Wang
    Nan Ding
    Yuran Dai
    Linshan Jiang
    Zhenrong Tang
    Yang Peng
    Shengchun Liu
    International Journal of Clinical Oncology, 2022, 27 : 899 - 910